Hylenex Recombinant (Hyaluronidase) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Hylenex Recombinant. Always confirm against the full prescribing information.
99 interactions
Acetylsalicylic acid
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Acetylsalicylic acid.
Level 1 evidence
Amitriptyline
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Amitriptyline.
Level 1 evidence
Aripiprazole
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aripiprazole.
Level 1 evidence
Aripiprazole lauroxil
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Aripiprazole lauroxil.
Level 1 evidence
Articaine
Hyaluronidase (human recombinant) can cause an increase in the absorption of Articaine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 1 evidence
Azelastine
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Azelastine.
Level 1 evidence
Benzatropine
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Benzatropine.
Level 1 evidence
Benzocaine
Hyaluronidase (human recombinant) can cause an increase in the absorption of Benzocaine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 1 evidence
Benzyl alcohol
Hyaluronidase (human recombinant) can cause an increase in the absorption of Benzyl alcohol resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 1 evidence
Betamethasone
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Betamethasone.
Level 1 evidence
Brompheniramine
The therapeutic efficacy of Hyaluronidase (human recombinant) can be decreased when used in combination with Brompheniramine.
Level 1 evidence
Bupivacaine
Hyaluronidase (human recombinant) can cause an increase in the absorption of Bupivacaine resulting in an increased serum concentration and potentially a worsening of adverse effects.
Level 1 evidence
Enter your NPI to unlock 23 major interactions for Hylenex Recombinant
Hylenex Recombinant (Hyaluronidase) has 99 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Hylenex Recombinant (Hyaluronidase) has 23 major, 0 moderate, and 76 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Hylenex Recombinant. Always confirm against the full prescribing information.